236 related articles for article (PubMed ID: 1437150)
21. Differential regulation of proto-oncogenes c-jun and c-fos in T lymphocytes activated through CD28.
Chatta GS; Spies AG; Chang S; Mize GJ; Linsley PS; Ledbetter JA; Morris DR
J Immunol; 1994 Dec; 153(12):5393-401. PubMed ID: 7989745
[TBL] [Abstract][Full Text] [Related]
22. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin.
Lin JK; Chen YC; Huang YT; Lin-Shiau SY
J Cell Biochem Suppl; 1997; 28-29():39-48. PubMed ID: 9589348
[TBL] [Abstract][Full Text] [Related]
23. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
24. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.
Tsuboi A; Muramatsu M; Tsutsumi A; Arai K; Arai N
Biochem Biophys Res Commun; 1994 Mar; 199(2):1064-72. PubMed ID: 8135780
[TBL] [Abstract][Full Text] [Related]
25. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
26. AP-1 complex and c-fos transcription are involved in TPA provoked and trans-synaptic inductions of the tyrosine hydroxylase gene: insights into long-term regulatory mechanisms.
Icard-Liepkalns C; Biguet NF; Vyas S; Robert JJ; Sassone-Corsi P; Mallet J
J Neurosci Res; 1992 Jun; 32(2):290-8. PubMed ID: 1383560
[TBL] [Abstract][Full Text] [Related]
27. Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2.
Andersson G; Påhlman S; Parrow V; Johansson I; Hammerling U
Cell Growth Differ; 1994 Jan; 5(1):27-36. PubMed ID: 8123590
[TBL] [Abstract][Full Text] [Related]
28. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
[TBL] [Abstract][Full Text] [Related]
29. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
[TBL] [Abstract][Full Text] [Related]
30. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
Carbone A; Gusella GL; Radzioch D; Varesio L
Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
[TBL] [Abstract][Full Text] [Related]
31. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
33. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
34. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
35. Activation of Jun/AP-1 by protein kinase A.
de Groot RP; Sassone-Corsi P
Oncogene; 1992 Nov; 7(11):2281-6. PubMed ID: 1331936
[TBL] [Abstract][Full Text] [Related]
36. Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity.
Hilberg F; Wagner EF
Oncogene; 1992 Dec; 7(12):2371-80. PubMed ID: 1281302
[TBL] [Abstract][Full Text] [Related]
37. Mapping of an inducible element in the T cell receptor V beta 2 promoter.
Messier H; Ratanavongsiri J; Fuller T; Mangal S; Kilgannon P; Fotedar R; Fotedar A
J Immunol; 1992 Sep; 149(6):1980-6. PubMed ID: 1387667
[TBL] [Abstract][Full Text] [Related]
38. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis.
Lu YP; Chang RL; Lou YR; Huang MT; Newmark HL; Reuhl KR; Conney AH
Carcinogenesis; 1994 Oct; 15(10):2363-70. PubMed ID: 7955078
[TBL] [Abstract][Full Text] [Related]
39. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
Dong Z; Birrer MJ; Watts RG; Matrisian LM; Colburn NH
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):609-13. PubMed ID: 8290571
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells.
Fung H; Quinlan TR; Janssen YM; Timblin CR; Marsh JP; Heintz NH; Taatjes DJ; Vacek P; Jaken S; Mossman BT
Cancer Res; 1997 Aug; 57(15):3101-5. PubMed ID: 9242432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
